Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14N4O2 |
InChIKeyQCFABHKBPWVNPW-UHFFFAOYSA-N |
CAS Registry1340867-76-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 14 Mar 2022 |